Microbiology of infected poison ivy dermatitis

British Journal of Dermatology

Volumn 142, Issue 5, 2000, Pages 943-946

  Brook, Itzhak ^a,b   Frazier, E H ^a   Yeager, J K ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Anaerobic bacteria; Beta lactamase; Infection; Poison ivy; Staphylococcus aureus

Indexed keywords

BETA LACTAMASE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIOLOGY; BACTEROIDES FRAGILIS; CLINICAL ARTICLE; CONTACT DERMATITIS; FEMALE; FUSOBACTERIUM; HUMAN; MALE; PEPTOSTREPTOCOCCUS; POISON IVY; PORPHYROMONAS; PREVOTELLA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A;

BACTERIAL INFECTIONS; BACTEROIDES FRAGILIS; BETA-LACTAMASES; DERMATITIS, TOXICODENDRON; FUSOBACTERIUM; HUMANS; PEPTOSTREPTOCOCCUS; PORPHYROMONAS; PREVOTELLA; RETROSPECTIVE STUDIES; SKIN DISEASES, BACTERIAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS;

EID: 0034071569     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03475.x     Document Type: Article

References (19)

1. 1 Kligman AM. Poison ivy (Rhus) dermatitis. Arch Dermatol 1958; 77: 149-80.
2. 2 Doyle JH. Poison ivy dermatitis. Pediatr Clin N Am 1961; 8: 259-63.
3. 3 Hanifin J, Rogge JL. Staphylococcal infections in patients with atopic dermatitis. Arch Dermatol 1977; 113: 1383-6.
4. 4 Williford PM, Sheretz EF. Poison ivy dermatitis. Nuances in treatment. Arch Fam Med 1994; 3: 184-8.
5. 5 Summanen P, Baron EJ. Citron DM et al. Wadsworth Anaerobic Bacteriology Manual, 5th edn. Belmont, CA: Star Publishing, 1993.
6. 6 Murray PR, Baron EJ. Pfalter MA et al. Manual of Clinical Microbiology, 6th edn. Washington, DC: American Society for Microbiology, 1995.
7. 7 O'Callaghan DH, Morris A, Kirby SM, Shingler AH. Novel method for detection of beta-lactamase by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother 1972; 1: 283-8.
8. 8 McFadden JP, Noble WC, Camp RD. Superantigenic exotoxinsecreting potential of staphylococci isolated from atopic eczematous skin. Br J Dermatol 1993; 128: 631-2.
9. 9 Brook I. Indigenous microbial flora of humans. In: Surgical Infectious Diseases (Howard R, Simmons RL, eds), 3rd edn. Appleton and Lange: Norwalk, CT: 1995: 37-46.
10. 10 Meilslin HW, Lerner SA, Graves MH et al. Cutaneous abscesses: anaerobic and aerobic bacteriology and outpatient management. Ann Intern Med 1977; 97: 145-51.
11. 11 Brook I, Finegold SM. Aerobic and anaerobic bacteriology of cutaneous abscesses in children. Pediatrics 1981; 67: 891-5.
12. 12 Brook I, Randolph J. Aerobic and anaerobic flora of burns in children. J Trauma 1981; 21: 313-18.
13. 13 Meleney FL. Bacterial synergy in disease processes. Ann Surg 1931; 22: 961-81.
14. 14 Brook I, Hunter V, Walker RI. Synergistic effects of Bacteroides, clostridia, fusobacteria, anaerobic cocci, and aerobic bacteria on mortality and induction of subcutaneous abscess in mice. J Infect Dis 1984: 149: 924-8.
15. 15 Brook I. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis 1984; 6: 601-7.
16. 16 Carpenter CB. Immunosuppression in organ transplantation. N Engl J Med 1990; 322: 1224-6.
17. 17 Sapico FL, Witte JL, Canawati HN et al. The infected foot of the diabetic patient: quantitative microbiology and analysis of clinical features. Rev Infect Dis 1984; 6 (Suppl. 1): S171-6.
18. 18 Brook I. Microbiological studies of decubitus ulcers in children. J Pediatr Surg 1991; 26: 207-9.
19. 19 Brook I. Microbiology of human and animal bite wounds in children. Pediatr Infect Dis J 1987; 6: 29-32.